Bionano Genomics, Inc.
BNGO
$1.18
-$0.02-1.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.03% | 0.96% | -7.37% | -13.84% | -25.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.03% | 0.96% | -7.37% | -13.84% | -25.02% |
| Cost of Revenue | -39.17% | -45.51% | -49.59% | -54.27% | 0.22% |
| Gross Profit | 934.27% | 2,632.39% | 3,369.47% | 2,304.01% | -86.92% |
| SG&A Expenses | -11.05% | -18.36% | -33.04% | -36.02% | -48.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.17% | -29.43% | -42.57% | -48.42% | -45.45% |
| Operating Income | 36.50% | 44.17% | 56.66% | 60.77% | 52.45% |
| Income Before Tax | 56.80% | 62.31% | 76.49% | 71.61% | 63.60% |
| Income Tax Expenses | 57.14% | 18.97% | 100.00% | 900.00% | 281.82% |
| Earnings from Continuing Operations | 56.73% | 62.25% | 76.44% | 71.58% | 63.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.73% | 62.25% | 76.44% | 71.58% | 63.58% |
| EBIT | 36.50% | 44.17% | 56.66% | 60.77% | 52.45% |
| EBITDA | 39.58% | 48.36% | 62.14% | 65.40% | 59.47% |
| EPS Basic | 91.87% | 91.29% | 94.10% | 88.48% | 85.03% |
| Normalized Basic EPS | 86.02% | 87.76% | 92.29% | 90.78% | 85.00% |
| EPS Diluted | 91.87% | 91.29% | 94.10% | 88.48% | 85.03% |
| Normalized Diluted EPS | 86.02% | 87.76% | 92.29% | 90.78% | 85.00% |
| Average Basic Shares Outstanding | 314.20% | 335.71% | 328.30% | 220.00% | 183.26% |
| Average Diluted Shares Outstanding | 314.20% | 335.71% | 328.30% | 220.00% | 183.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |